A twice-yearly shot of this drug could help end AIDS - 'it's unprecedented'
Briefly

The drug called lenacapavir is already sold under the brand name Sunlenca to treat HIV infections in the U.S., Canada, Europe and elsewhere.
UNAIDS said that the number of AIDS deaths last year—an estimated 630,000—was at its lowest since peaking in 2004, suggesting the world is now at a historic crossroads.
Experts say the Gilead twice-yearly shots would be particularly useful for marginalized people often fearful of seeking care, including gay men, sex workers and young women.
Winnie Byanyima emphasized that this vaccine, being 'so far superior to any other prevention method we have,' presents an unprecedented opportunity to combat AIDS.
Read at Fortune
[
|
]